Stockreport

A Look At BioCryst Pharmaceuticals (BCRX) Valuation As Undervalued Narrative Gains Traction [Yahoo! Finance]

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations
PDF See our latest analysis for BioCryst Pharmaceuticals. Recent trading reflects a shift in sentiment, with a 4.49% 1 day share price return and 9.24% 90 day share price [Read more]